Journal of Applied Physiology, Vol 74, Issue 3 982-988, Copyright © 1993 by American Physiological Society

ARTICLES

Adenosine prevents PMA-induced lung injury via an A2 receptor mechanism

W. K. Adkins, J. W. Barnard, T. M. Moore, R. C. Allison, V. R. Prasad and A. E. Taylor
Department of Physiology, College of Medicine, University of South Alabama, Mobile 36688.

Previous studies indicate that adenosine attenuates phorbol myristate acetate-(PMA) induced canine lung injury, but the mechanism has not been explained. To evaluate adenosine's protective mechanism, isolated and blood-perfused dog lungs were challenged by PMA (50 micrograms) under control conditions and after both pre- and post-treatment with adenosine and pretreatment with 2-chloro-N6-cyclopentyladenosine (CCPA), 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido adenosine (CGS 21680C), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; PD-116948), or isoproterenol. Injury was assessed by measurement of the capillary filtration coefficient (Kf,c), and pulmonary vascular resistance was measured. PMA increased the Kf,c (0.170 +/- 0.015 to 1.030 +/- 0.167 ml.min-1.cmH2O-1.100 g lung wet wt-1) and the total pulmonary vascular resistance (18.2 +/- 3.8 to 110.2 +/- 60.8 cmH2O.l-1.min.100 g lung wet wt). Pretreatment with adenosine, A2 agonist, A1 antagonist, and isoproterenol blocked the increase in Kf,c induced by PMA. These agents also slightly attenuated the resistance increase induced by PMA, with the exception of the A1 antagonist, which completely prevented the resistance increase (24.3 +/- 7.8 to 23.4 +/- 8.1 cmH2O.l-1.min.100 g lung wet wt). The A1 agonist also slightly attenuated the increase in Kf,c (0.174 +/- 0.022 to 0.486 +/- 0.128 ml.min-1.cmH2O-1.100 g lung wet wt-1) and did not affect the resistance increase. Posttreatment with adenosine did not significantly affect the changes induced by PMA. These data show that PMA-induced increases in capillary permeability in the isolated blood-perfused dog lung can be blocked by pretreatment with adenosine, which binds the adenosine A2 receptors.

This article has been cited by other articles:

				H. T. Lee and C. W. Emala Preconditioning and Adenosine Protect Human Proximal Tubule Cells in an In Vitro Model of Ischemic Injury J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2753 - 2761. [Abstract] [Full Text] [PDF]

				F. Liu, A. D. Verin, T. Borbiev, and J. G. N. Garcia Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1309 - L1317. [Abstract] [Full Text] [PDF]

				P. F. Lennon, C. T. Taylor, G. L. Stahl, and S. P. Colgan Neutrophil-derived 5'-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation J. Exp. Med., October 19, 1998; 188(8): 1433 - 1443. [Abstract] [Full Text] [PDF]

				T. M. Moore, P. M. Chetham, J. J. Kelly, and T. Stevens Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L203 - L222. [Abstract] [Full Text] [PDF]

				S. Patil, J. E. Kaplan, and F. L. Minnear Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2304 - H2311. [Abstract] [Full Text] [PDF]

				H. T. Lee and C. W. Emala Adenosine attenuates oxidant injury in human proximal tubular cells via A1 and A2a adenosine receptors Am J Physiol Renal Physiol, May 1, 2002; 282(5): F844 - F852. [Abstract] [Full Text] [PDF]